Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens
Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens
- # Allogeneic Hematopoietic Stem Cell Transplantation
- # Acute Graft-vs-host Disease
- # anti-HLA Antibodies
- # PubMed Scopus
- # Allogeneic Peripheral Blood Hematopoietic Stem
- # Presence Of anti-HLA Antibodies
- # Reduced-intensity Conditioning Regimen
- # Full Text PDF PubMed Scopus
- # Human Leukocyte Antigen
- # Google Scholar
- Research Article
21
- 10.1016/j.bbmt.2012.10.028
- Oct 27, 2012
- Biology of Blood and Marrow Transplantation
Graft-versus-Host Disease: State of the Science
- Research Article
41
- 10.1016/j.bbmt.2009.09.020
- Sep 26, 2009
- Biology of Blood and Marrow Transplantation
Improved Outcomes Using Tacrolimus/Sirolimus for Graft-versus-Host Disease Prophylaxis with a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as treatment of Myelofibrosis
- Research Article
27
- 10.1111/j.1523-1747.2004.23211.x
- Aug 1, 2004
- Journal of Investigative Dermatology
Update on graft versus host disease.
- Research Article
63
- 10.1016/j.exphem.2008.01.017
- Mar 17, 2008
- Experimental Hematology
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire
- Research Article
100
- 10.1016/j.bbmt.2010.05.007
- May 26, 2010
- Biology of Blood and Marrow Transplantation
Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- Research Article
17
- 10.1016/j.exphem.2013.09.012
- Oct 2, 2013
- Experimental Hematology
Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma
- Research Article
71
- 10.1016/j.bbmt.2011.10.008
- Oct 17, 2011
- Biology of Blood and Marrow Transplantation
Comparison of Unrelated Cord Blood Transplantation and HLA-Mismatched Unrelated Bone Marrow Transplantation for Adults with Leukemia
- Research Article
33
- 10.1016/j.bbmt.2010.10.031
- Nov 1, 2010
- Biology of Blood and Marrow Transplantation
Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
- Research Article
20
- 10.1016/j.bbmt.2011.04.009
- Apr 27, 2011
- Biology of Blood and Marrow Transplantation
Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 Patients
- Research Article
23
- 10.1016/j.bbmt.2010.04.013
- May 10, 2010
- Biology of Blood and Marrow Transplantation
Immunosuppressive Cytokine Gene Polymorphisms and Outcome after Related and Unrelated Hematopoietic Cell Transplantation in a Chinese Population
- Research Article
36
- 10.1016/j.exphem.2012.01.006
- Jan 17, 2012
- Experimental Hematology
Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy
- Research Article
76
- 10.1016/j.bbmt.2010.02.006
- Feb 12, 2010
- Biology of Blood and Marrow Transplantation
Chronic Kidney Disease, Thrombotic Microangiopathy, and Hypertension Following T Cell-Depleted Hematopoietic Stem Cell Transplantation
- Research Article
212
- 10.1016/j.bbmt.2010.09.012
- Sep 24, 2010
- Biology of Blood and Marrow Transplantation
HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Research Article
16
- 10.1016/j.jaci.2017.05.007
- May 26, 2017
- Journal of Allergy and Clinical Immunology
Hematopoietic stem cell transplantation for RelB deficiency
- Research Article
136
- 10.1016/j.bbmt.2010.08.001
- Aug 8, 2010
- Biology of Blood and Marrow Transplantation
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation